Poonam Piplani
Overview
Explore the profile of Poonam Piplani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piplani P, Kumar A, Kulshreshtha A, Vohra T, Piplani V
Mini Rev Med Chem
. 2023 Nov;
24(10):1001-1030.
PMID: 37909434
Antibiotic or antimicrobial resistance is an urgent global public health threat that occurs when bacterial or fungal infections do not respond to the drug regimen designed to treat these infections....
2.
Sharma A, Piplani P
Curr Top Med Chem
. 2023 Feb;
23(13):1260-1276.
PMID: 36740790
Alzheimer's disease (AD) is drawing scientists' consideration, being one of the gravest diseases mankind will have to battle against in the near future. The number of people with AD is...
3.
Bala M, Piplani P, Ankalgi A, Jain A, Chandel L
Med Chem
. 2023 Jan;
19(8):730-756.
PMID: 36593699
The 1,3,4-thiadiazole nucleus has attracted the attention of medicinal chemists during the last decades due to its multiple pharmacological activities, such as antiviral, anticancer, antibacterial, and anticonvulsant activity. This scaffold's...
4.
Silakari P, Silakari O, Piplani P
ACS Chem Neurosci
. 2021 Apr;
12(9):1648-1666.
PMID: 33852798
Cholinesterases are significant biological targets for the regulation of cholinergic neurotransmission, and their inhibitors are being exploited for the management of cognitive decline in various neurological conditions. The 1,4-benzoquinone scaffold...
5.
Jain A, Piplani P
Bioorg Chem
. 2020 Sep;
103:104151.
PMID: 32871346
Acetylcholinesterase has been a promising target for the development of putative therapeutics against cognitive decline. The deleterious effect of oxidative stress on the learning and memory paradigms of an individual...
6.
Danta C, Piplani P
ACS Chem Neurosci
. 2020 Jun;
11(14):2034-2038.
PMID: 32573244
HIV-associated neurocognitive disorder (HAND) can be represented by neurological and neuropathological abnormalities with a consequence of motor and cognitive loss. It has become a critical unmet medical need for infected...
7.
Silakari P, Priyanka , Piplani P
Mini Rev Med Chem
. 2020 Apr;
20(16):1586-1609.
PMID: 32348217
Quinones are a huge class of compounds with affluent and captivating chemistry. p-Benzoquinone (p-BNZ) or 1,4-Benzoquinone is the key structural motif of numerous biologically active synthetic and natural compounds. This...
8.
Jain A, Piplani P
Mini Rev Med Chem
. 2019 Mar;
19(16):1298-1368.
PMID: 30864516
Triazole is a valuable platform in medicinal chemistry, possessing assorted pharmacological properties, which could play a major role in the common mechanisms associated with various disorders like cancer, infections, inflammation,...
9.
Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Abbhi V, Piplani P
Curr Med Chem
. 2018 Nov;
27(14):2222-2256.
PMID: 30378487
Background: Glaucoma is a progressive optic neuropathy causing visual impairment and Retinal Ganglionic Cells (RGCs) death gradually posing a need for neuroprotective strategies to minimize the loss of RGCs and...
10.
Piplani P, Jain A, Devi D, Anjali , Sharma A, Silakari P
Bioorg Med Chem
. 2017 Dec;
26(1):215-224.
PMID: 29195794
The present study reports the effect of indanone derivatives on scopolamine induced deficit cholinergic neurotransmission serving as promising leads for the therapeutics of cognitive dysfunction. Eleven compounds 54-64 have been...